Axsome Therapeutics AXSM Edges Higher Near Resistance as Biotech Momentum Builds Indian Equity Benchmarks Witness Sharp Decline Amid Profit Booking and USIran Concerns UAMY Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Trumps 18 Billion AntiWeaponization Fund Temporarily Halted by Court Order